Compare · POCI vs TMDX
POCI vs TMDX
Side-by-side comparison of Precision Optics Corporation Inc. (POCI) and TransMedics Group Inc. (TMDX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both POCI and TMDX operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- TMDX is the larger of the two at $2.56B, about 53.8x POCI ($47.5M).
- TMDX has hit the wire 4 times in the past 4 weeks while POCI has been quiet.
- TMDX has more recent analyst coverage (18 ratings vs 0 for POCI).
- Company
- Precision Optics Corporation Inc.
- TransMedics Group Inc.
- Price
- $4.31-6.30%
- $74.01-2.55%
- Market cap
- $47.5M
- $2.56B
- 1M return
- -27.01%
- -
- 1Y return
- -11.86%
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- News (4w)
- 0
- 4
- Recent ratings
- 0
- 18
TransMedics Group Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.
Latest POCI
- Precision Optics to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
- Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
- Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results
- SEC Form 10-Q filed by Precision Optics Corporation Inc.
- New insider Needham Investment Management Llc claimed ownership of 3,341,100 shares (SEC Form 3)
- Precision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026
- Precision Optics Announces Receipt of $3.5 Million Follow-On Production Order for Single-Use Ophthalmic Program
- SEC Form 3 filed by new insider Needham Investment Management Llc
- SEC Form 4 filed by Coll Wayne M
- SEC Form 4 filed by Traut Joseph
Latest TMDX
- Officer Corcoran Nicholas was granted 11,727 shares, increasing direct ownership by 39% to 41,558 units (SEC Form 4)
- Chief Financial Officer Hernandez Gerardo was granted 17,246 shares, increasing direct ownership by 117% to 31,935 units (SEC Form 4)
- President & CEO Hassanein Waleed H was granted 49,669 shares, increasing direct ownership by 41% to 171,093 units (SEC Form 4)
- TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH
- Director Gunderson Thomas J. exercised 19,285 shares at a strike of $2.21 and sold $722,377 worth of shares (9,624 units at $75.06), increasing direct ownership by 138% to 16,642 units (SEC Form 4) (for withholding tax)
- SEC Form 144 filed by TransMedics Group Inc.
- SEC Form SD filed by TransMedics Group Inc.
- Director Basile Edward M was granted 2,922 shares, increasing direct ownership by 102% to 5,788 units (SEC Form 4)
- Director Gunderson Thomas J. was granted 2,922 shares, increasing direct ownership by 72% to 6,981 units (SEC Form 4)
- Director Raines Merilee was granted 2,922 shares, increasing direct ownership by 72% to 6,981 units (SEC Form 4)